Evaluation of Liposomal and Microbubbles Mediated Delivery of Doxorubicin in Two-Dimensional (2D) and Three-Dimensional (3D) Models for Breast Cancer.

Objective Liposomal cancer treatment strategies are useful in removing the side effects that were the main concern in recent years. In this study, we prepared microbubble (MBs) conjugated with DOX-loaded liposomes (DOX-loaded MBs) and investigated their effectiveness in in vitro breast cancer cells in two dimensions (2D) and three dimensions (3D). Materials and Methods With this aim, breast cancer cells with different features (4T1, MDA-MB231, MCF-7) were growth in 2D and 3D dimensions. The cytotoxic and cell death effects under different conditions, durations and doses were evaluated with WST-1, trypan-blue, colony counts. Apoptotic effects were investigated with flow cytometric Annexin-V-PI and immunohistochemical (Ki-67, caspase 3, 8, 9) methods. Results After free DOX and LipoDOX were applied, the proliferation index of three cell lines reduced. Intrinsic and extrinsic apoptotic pathways were activated in both 2D and 3D models. However, this effect was observed at lower levels in the 3D model due to the difficulty of diffusion of DOX into the spheroids. Additionally, the suitability of the 3D model for breast cancer cells was supported by formation of ductus-like structures and spheroids. Cell deaths were not observed significantly with the DOX-loaded microbubbles due to rising of MBs to the surface and not reaching spheroids held in matrigel of 3D model. Conclusion DOX and LipoDOX showed anti-proliferative and apoptosis-inducing effects in breast cancer cells. However, these effects indicated variability depending on the cell lines and 2D or 3D model types.

[1]  J. Bamber,et al.  Theranostic Attributes of Acoustic Cluster Therapy and Its Use for Enhancing the Effectiveness of Liposomal Doxorubicin Treatment of Human Triple Negative Breast Cancer in Mice , 2020, Frontiers in Pharmacology.

[2]  J. Sparano,et al.  Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up , 2020, Cancer Chemotherapy and Pharmacology.

[3]  Ting Zhao,et al.  A new tandem peptide modified liposomal doxorubicin for tumor "ecological therapy". , 2020, Nanoscale.

[4]  A. Nikpoor,et al.  Doxil chemotherapy plus liposomal P5 immunotherapy decreased myeloid-derived suppressor cells in murine model of breast cancer. , 2020, Nanomedicine : nanotechnology, biology, and medicine.

[5]  Cansu Önercan.  Development of ultrasound triggered drug delivery systems for cancer treatment , 2019 .

[6]  Yuan Luo,et al.  Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer , 2019, Artificial cells, nanomedicine, and biotechnology.

[7]  C. Raut,et al.  Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies , 2018, CA: a cancer journal for clinicians.

[8]  S. Narod.  Personalised medicine and population health: breast and ovarian cancer , 2018, Human Genetics.

[9]  T. Mukohara,et al.  Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. , 2015, Oncology reports.

[10]  B. Weigelt,et al.  The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. , 2014, Advanced drug delivery reviews.

[11]  M. Smalley,et al.  Breast cancer stem cells: obstacles to therapy. , 2013, Cancer letters.

[12]  Kate Lawrenson,et al.  A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro , 2013, Laboratory Investigation.

[13]  Win-Li Lin,et al.  Enhancement of focused ultrasound with microbubbles on the treatments of anticancer nanodrug in mouse tumors. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[14]  Maria Vinci,et al.  Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation , 2012, BMC Biology.

[15]  John Eisenbrey,et al.  Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. , 2011, International journal of pharmaceutics.

[16]  G. Winter,et al.  New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[17]  F. Martin,et al.  Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies. , 2004, Seminars in oncology.

[18]  Ana M Soto,et al.  The stroma as a crucial target in rat mammary gland carcinogenesis , 2004, Journal of Cell Science.

[19]  R. Wooster,et al.  Breast and ovarian cancer. , 2003, The New England journal of medicine.